Research Nester Logo.jpg
Dietary Fibers Market revenue to surpass USD 15 Billion by 2035, says Research Nester
January 16, 2024 08:00 ET | Research Nester
New York, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The global dietary fibers market size is predicted to expand at ~7% CAGR between 2023 and 2035. The market is projected to garner a revenue of USD 15...
AMR Logo.png
Global Cell-Based Assay Market to Generate $26.34 Billion by 2030: Allied Market Research
March 22, 2022 09:31 ET | Allied Market Research
Portland, OR, March 22, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Cell-Based Assay Market generated $11.74 billion in 2020, and is expected to...
DCRI Receives Top Customer Loyalty Scores in ISR's 6th Annual CRO Quality Benchmarking Study
March 19, 2014 13:09 ET | Industry Standard Research
CARY, NC--(Marketwired - Mar 19, 2014) - Industry Standard Research (ISR) is announcing the launch of its 6th annual CRO Quality Benchmarking series with today's release of its "CRO Quality...
Women First HealthCare Reports First Quarter Profit of $0.01 Per Share vs. Loss of $0.05 Per Share in Prior Year; Revenue Up 33 Percent
April 29, 2002 16:08 ET | Women First HealthCare, Inc.
SAN DIEGO, April 29, 2002 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) today announced a first quarter 2002 profit of $243,000, or $0.01 per fully diluted share, on total revenues of...
Competitive Technologies Licensee Presents PT-141 Data
October 26, 2001 12:48 ET | Competitive Technologies, Inc.
FAIRFIELD, Conn., Oct. 26, 2001 (PRIMEZONE) -- Competitive Technologies, Inc. (AMEX:CTT) announced today that scientists at its exclusive licensee Palatin Technologies, Inc. (AMEX:PTN), in...
Competitive Technologies Licensee Begins New Cancer Trial
September 25, 2001 13:29 ET | Competitive Technologies, Inc.
FAIRFIELD, Conn., Sept. 25, 2001 (PRIMEZONE) Competitive Technologies, Inc. (AMEX:CTT) reported today that its licensee, Ribozyme Pharmaceuticals Inc. (Nasdaq:RZYM) announced the start of the third...